ADRB2 and Parkinson disease: In order to validate the hypothesis that drugs employed in the treatment of PD could display binding conformations similar to those observed for L-DOPA and Droxidopa, we also performed the molecular docking of carbidopa, foslevodopa and foscarbidopa to a rigid β2AR model using the latest version of Vina (v.